PUBLISHER: Grand View Research | PRODUCT CODE: 1552589
PUBLISHER: Grand View Research | PRODUCT CODE: 1552589
The global PET scanners market is expected to reach USD 3.37 billion by 2030 to expand at a CAGR of 3.65% from 2024 to 2030 based on a new report by Grand View Research, Inc. An increasing prevalence of cancer patients globally and the growing demand for PET analysis in radiopharmaceuticals are expected to propel the growth of the market. Digital PET scanners use advanced detectors that can precisely measure the amount of radiation emitted by the tracer. This allows for higher spatial and temporal resolution, reducing noise and improving image quality. Combining PET and magnetic resonance imaging (MRI) allows for the simultaneous acquisition of metabolic and anatomical information, which can improve the accuracy of diagnosis and helps in planning treatment.
Furthermore, the increased use of artificial intelligence (AI) in PET scanners has the potential to enhance image quality, reduce radiation exposure for patients, and automate certain tasks to improve efficiency and accuracy in medical imaging. For instance, in October 2022, Blue Earth Diagnostics, a global provider of innovative PET radiopharmaceuticals signed an agreement of a data-sharing with Siemens Healthineers, a major medical device company, and the University Hospital of the Technical University of Munich (TUM) for 18F-rhPSMA-7.3, an Investigational PET Imaging Agent, to support AI-based algorithms development. Siemens Healthineers intends to evaluate the data to improve its analytics and AI-based algorithms for prostate cancer across its innovative PET/CT imaging software. However, as AI technology continues to advance, it is likely to drive the growth of the PET scanners market in the future.